Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional level by Roe, Andrew J et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Heterogeneous surface expression of EspA translocon filaments
by Escherichia coli O157:H7 is controlled at the
posttranscriptional level
Citation for published version:
Roe, AJ, Yull, H, Naylor, SW, Woodward, MJ, Smith, DGE & Gally, DL 2003, 'Heterogeneous surface
expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional
level' Infection and Immunity, vol 71, no. 10, pp. 5900-9. DOI: 10.1128/IAI.71.10.5900-5909.2003
Digital Object Identifier (DOI):
10.1128/IAI.71.10.5900-5909.2003
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Infection and Immunity
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
INFECTION AND IMMUNITY, Oct. 2003, p. 5900–5909 Vol. 71, No. 10
0019-9567/03/$08.000 DOI: 10.1128/IAI.71.10.5900–5909.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Heterogeneous Surface Expression of EspA Translocon Filaments by
Escherichia coli O157:H7 Is Controlled at the
Posttranscriptional Level
Andrew J. Roe,1 Helen Yull,1 Stuart W. Naylor,1 Martin J. Woodward,2 David G. E. Smith,1 and
David L. Gally1*
Zoonotic and Animal Pathogens Research Laboratory, Medical Microbiology, University of Edinburgh, Edinburgh
EH8 9AG,1 and Veterinary Laboratory Agency, Addlestone, Surrey KT15 3NB,2 United Kingdom
Received 17 March 2003/Returned for modification 12 June 2003/Accepted 24 July 2003
Type III secretion systems of enteric bacteria enable translocation of effector proteins into host cells.
Secreted proteins of verotoxigenic Escherichia coli O157 strains include components of a translocation appa-
ratus, EspA, -B, and -D, as well as “effectors” such as the translocated intimin receptor (Tir) and the
mitochondrion-associated protein (Map). This research has investigated the regulation of LEE4 translocon
proteins, in particular EspA. EspA filaments could not be detected on the bacterial cell surface when E. coli
O157:H7 was cultured in M9 minimal medium but were expressed from only a proportion of the bacterial
population when cultured in minimal essential medium modified with 25 mM HEPES. The highest proportions
of EspA-filamented bacteria were detected in late exponential phase, after which filaments were lost rapidly
from the bacterial cell surface. Our previous research had shown that human and bovine E. coli O157:H7
strains exhibit marked differences in EspD secretion levels. Here it is demonstrated that the proportion of the
bacterial population expressing EspA filaments was associated with the level of EspD secretion. The ability of
individual bacteria to express EspA filaments was not controlled at the level of LEE1-4 operon transcription,
as demonstrated by using both -galactosidase and green fluorescent protein (GFP) promoter fusions. All
bacteria, whether expressing EspA filaments or not, showed equivalent levels of GFP expression when LEE1-4
translational fusions were used. Despite this, the LEE4-espADB mRNA was more abundant from populations
with a high proportion of nonsecreting bacteria (low secretors) than from populations with a high proportion
of secreting and therefore filamented bacteria (high secretors). This research demonstrates that while specific
environmental conditions are required to induce LEE1-4 expression, a further checkpoint exists before EspA
filaments are produced on the bacterial surface and secretion of effector proteins occurs. This checkpoint in E.
coli O157:H7 translocon expression is controlled by a posttranscriptional mechanism acting on LEE4-espADB
mRNA. The heterogeneity in EspA filamentation could arise from phase-variable expression of regulators that
control this posttranscriptional mechanism.
A number of gram-negative enteric pathogens export effec-
tor proteins into host cells via a type III secretion system
(TTSS). These include Salmonella spp., Yersinia spp., Shigella
spp., and enteropathogenic and enterohemorrhagic Esche-
richia coli (EPEC and EHEC, respectively) (10, 18, 23, 26).
The effectors have numerous functions, including inhibition of
phagocytosis (8, 20), invasion (19), cytotoxicity (17, 27, 35), and
bacterial attachment (7, 33), mostly through effects on signal
transduction (3, 17, 24, 31, 34, 48, 55). In general, these TTSSs
comprise a basal apparatus, with proteins present in the inner
and outer membranes, and a needle complex that allows in-
jection of effector proteins through the host cell membrane
(10, 26, 47, 53, 61). In EPEC and EHEC, EscF is considered to
form a short needle that is elongated by a filament made up of
EspA (61). The EspA filaments allow formation of a pore in
the host cell membrane involving the secreted proteins EspD
and EspB (36, 53, 54). The EspA filaments have been shown to
be produced transiently during lesion formation, and their loss
from the surface potentially allows the subsequent intimate
interaction of the bacterial surface factor intimin and the trans-
located intimin receptor (Tir) (36).
EHEC O157 is considered to have originated from an EPEC
O55 strain that acquired Shiga-like toxin-carrying phage (50).
Both EHEC and EPEC strains carry the locus of enterocyte
effacement (LEE), which encodes a TTSS (15, 38, 39). At least
seven open reading frames are present, and the first three
encode proteins required for regulation and assembly of the
basal apparatus, LEE1-3 (6, 57). The next operon (LEE4)
encodes the secreted proteins EspA, EspB, and EspD (14, 36,
46, 58, 59), as well as factors whose function is not clear,
including SepL (37) and EspF (11, 41, 42). EPEC O127
(E2348/69) and EHEC O157:H7 (EDL933) differ in that the
cloned EPEC LEE, but not the cloned EHEC O157 LEE,
confers the ability to form attaching-and-effacing lesions on E.
coli K-12 (16, 39). This difference may reflect the biology of the
organisms, with EHEC O157 strains possibly behaving as com-
mensals in ruminant hosts, whereas EPEC strains are overt
animal and human pathogens. Among EHEC O157 strains
(Shiga-like toxin and intimin positive), there is marked varia-
tion in the ability to secrete Tir and EspD into tissue culture
medium (40). There was a correlation between high-secretor
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status, extent of attaching-and-effacing lesions, and strains of
human disease origin. Cattle isolates were more likely to be
low-level EspD secretors (40).
The aim of this study was to investigate the expression and
secretion of the translocon proteins EspA and EspD to under-
stand the heterogeneity in expression levels between isolates.
Immunofluorescence microscopy was used to demonstrate that
EspA filament expression was heterogeneous in all of the
EHEC O157 strains tested. The proportion of the bacterial
population expressing EspA filaments correlated with secreted
EspD levels. High EspD secretors had a higher proportion of
bacteria expressing EspA filaments than did low secretors. The
molecular basis of this expression pattern lay not with the
transcription of LEE4 or LEE1-3 but with a mechanism con-
trolling the translation of the LEE4-espADB mRNA transcript.
MATERIALS AND METHODS
Minimal media. Two defined media were used in this study, M9 minimal
medium and minimal essential medium modified with 25 mM HEPES (MEM-
HEPES). Glucose was added to the MEM-HEPES to give a final concentration
of 0.2%. M9 minimal medium was prepared with a final glucose concentration of
0.2% (52). Antibiotics were included, when required, at the following concen-
trations: chloramphenicol (CAM), 12.5 g/ml; kanamycin (KAN), 25 g/ml.
Protein analysis. Bacteria were cultured in MEM-HEPES to an optical density
at 600 nm (OD600) of 0.8. Secreted proteins were extracted by trichloroacetic
acid precipitation as described previously (40). For protein localization experi-
ments, whole-cell fractions were prepared by centrifugation (20 min, 4,000  g),
two washes in 20 ml of phosphate-buffered saline (PBS), and suspension in 400
l of protein A buffer (10 mM NaCl, 50 mM Tris-HCl [pH 7.6], 1 mM EDTA,
0.1 mM dithiothreitol). Membrane fractions were prepared by the method of
Kabach (28), with final suspension in 400 l of protein A buffer. Proteins were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and stained with Colloidal blue (Invitrogen, Groningen, The Nether-
lands). Western blotting for Esps was done with a polyclonal antibody for EspA
(60) and a monoclonal antibody against EspD (40). Bacteria were stained for
EspA filaments following fixation with 4% paraformaldehyde for 5 min. Aliquots
of fixed bacteria were air dried onto slides and incubated with a 1/100 dilution of
the EspA antibody (in PBS–0.1% bovine serum albumin [BSA])for 60 min at
room temperature. After three washes with PBS–0.1% BSA, the samples were
incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit immuno-
globulin antibody (1/500; Dako) for 30 min, and the slide was washed three times
with PBS–0.1% BSA. The slide was then examined by fluorescence microscopy
with appropriate filter sets, and the images were captured with Leica software.
Plasmid-based promoter-GFP fusion construction. In order to allow single-
cell levels of promoter activity to be determined, the enhanced green fluorescent
protein (GFP) gene (egfp), but without a promoter, was cloned into pACYC184.
Primers GFP 5 and GFP 3 (Table 1) were used to amplify the gfp gene from
peGFP (extended-half-life GFP; Clontech). These primers incorporate BamHI
(GFP 5) and BglII (GFP 3) sites at their termini, allowing cloning into the
BamHI site of pACYC184. All of the restriction enzymes used were from New
England Biolabs. The resultant plasmid (pAJR70) has single BamHI and KpnI
sites 5 of the gfp gene, allowing promoters of interest to be cloned in frame with
the reporter gene, creating translational fusions. Promoters for LEE1-4 were
amplified from ZAP193 and cloned into pAJR70 to create pAJR71–75 (Table 2).
These fusions provide a readout that is a combination of both transcription and
translation initiation activities. Any transcriptional regulation acting on the pro-
moter can be detected by using these fusions. As they also contain the wild-type
ribosome binding site, they provide a more realistic readout of gene expression
than a standard transcriptional fusion that uses a nonnative ribosome binding
site. These fusions, while described as translational, are unlikely to provide a
readout of other posttranscriptional control mechanisms, as the mRNA structure
of the fusions will differ completely from that of the wild-type transcript.
Quantification of GFP fusion levels. ZAP193 was transformed with
pAJR70–74 (Table 2) under standard conditions. The resultant transformants
were grown overnight in M9 minimal medium or MEM-HEPES containing
CAM and then diluted 1:50 into fresh, MEM-HEPES-CAM or M9 minimal
medium-CAM on the next morning. Typically, 15 ml was cultured in Erlenmeyer
flasks shaken at 200 rpm, 37°C. The optical density of the cultures was monitored
by determination of the OD600. At an OD600 of 0.8, a 20-l aliquot was removed
and smeared onto a glass slide. This was heat fixed (65°C, 15 min), passed briefly
through a Bunsen flame, and then chemically fixed by flooding of the slide with
4% paraformaldehyde. After 20 min, the slide was washed three times with PBS
and a coverslip was applied with DAKO fluorescent mounting medium. Images
were acquired on a Zeiss LSM 510 confocal system with single images of a
projected focus stack consisting of four optical sections with a depth of 0.7 m.
The total GFP produced by the population was determined by analyzing 100-l
aliquots of culture with a fluorescent plate reader (Fluorostar Optima; BMG).
Promoterless plasmid pAJR70 in ZAP193 acted as a control for background
fluorescence, which, at the appropriate OD, was subtracted from the other
values.
Creation of plasmids suitable for allelic exchange. In order to create plasmids
that would facilitate chromosomal exchange, flanking regions of the lac operon
were PCR amplified and cloned into a temperature-sensitive plasmid (pIB307;
Table 2). Primer pairs lacI 5-lacI 3 and lacA 5-lacA 3 were used to amplify
strain-specific lac sequences from E. coli O157:H7, ZAP193, and ZAP1. These
products were cleaned with a Qiagen PCR purification kit, digested with BamHI,
recleaned, and then ligated under standard conditions. One microliter of this
ligation reaction mixture was then used as a template for PCR with primers lacI
5 and lacA 3 to produce 1.4-kb lacIA fragments specific for each strain. These
fragments were digested with SacI and PstI and then cloned into the same sites
in pIB307 (Table 2) to produce pAJR26 (ZAP193) and pAJR27 (ZAP1). To
produce plasmids that would allow the chromosomal lacIA intergenic region to
be replaced with a selectable marker and a counterselection gene, a sac-kan
cassette was cloned into the BamHI sites of pAJR26 and pAJR27. The sac-kan
cassette from pDG28 (Table 2) was excised with BamHI, cleaned with the
Qiagen PCR cleanup kit, and ligated into pAJR26 and pAJR27 under standard
conditions. The resultant plasmids (pAJR33 and pAJR34) therefore had strain-
specific lacIA regions flanking a sac-kan cassette.
Creation of lac deletion strains. The method of Hamilton et al. (25) was used
for the allelic exchange of pAJR33 and pAJR34 into ZAP1 and ZAP193, re-
spectively. Plasmid pAJR33 was also used for allelic exchange of the lacZY genes
of ZAP41. Briefly, the strain to be manipulated was electroporated with the
plasmid containing the appropriate flanking regions and plated at 30°C on
Luria-Bertani broth (LB)-CAM plates. Ten transformants were then inoculated
into prewarmed LB-KAN at 42°C. After 48 h of growth in log phase at 42°C, a
TABLE 1. Oligonucleotide primers used in this study
Primers Sequencea
lacI 5 ............................gggggagctcCGTTATTTCTTGATGTCTCTGAC
lacI 3 ............................ggggatccGCCTGGGGTGCCTAATGAGTGAG
lacA 5 ...........................ccggatccAATGACCGAAAGAATAAGAG
lacA 3 ...........................aaaactgcagATGTCTTTTGTGACGATACT
lacZ 5 ...........................ccggatccggtaccATGACCATGATTACGGATTCAC
lacZ 3 ...........................ccagatctCCTTACGCGAAATACGGGC
pSepL 5........................cgggatccGATTGAGGCCTTGTTCAAGG
pSepL 3........................cgggtaccTTCAATACCATTAGCCATTGG
lacI up 5.......................CGCGGTATGGCATGATAGCG
lacA down 3.................CATGCCGGATGCGGCTAATG
lac mid 5 ......................GTGACGTCTGCTTGCTGCAT
lac mid 3 ......................CAGCAGGATATCCTGCACC
espA short 5.................ccggatccCGATTGTCGAAGATAAAC
espA short 3.................cggtgaccTGCATTTGATGTATCCAT
pgi probe 5...................ACATCAATCCAACGCAGACC
pgi probe 3...................TTCATCTTCTCCAGCACCGC
espA probe 5 ...............ACATCCGTTGTTAATGTGAGTGCG
espA probe 3 ...............GCAATTTTGGCATCCACAAG
sepL probe 5................ATCAAAACCCCGCATCTGTT
sepL probe 3................TTTCCTTGCGCTACCTTTGC
espD probe 5 ...............GCTTAACGTAAATAACGATACCCTG
espD probe 3 ...............CTCACCACTAATACCAAACAAT
escC probe 5................ATTCGCTAGATGCAGATTTTATCGG
escC probe 3................GTTACTTGATATTCAGGATGGC
lee1 5 ............................ccggatccCTGTAACTCGAATTAAGTAGAG
lee1 3 ............................ccggtaccGTATGGACTTGTTGTATGTGAATT
lee2 5 ............................cgggatccGCGAACGCGCTCAATAATCTG
lee2 3 ............................cgggtaccTGCTGCTTCCATTGATCTTTC
lee3 5 ............................cgggatccCTGCTCGTCTCCGAGCATGCC
lee3 3 ............................cgggtaccAACTAAAAGATTCATCTGCAGGCT
GFP 5...........................ccggatccggggtaccATGGTGAGCAAGGGCGAGGAGC
GFP 3...........................cgggtaccAACTAAAAGATTCATCTGCAGGCT
a The lowercase portions of some sequences are nonmatching sequence incor-
porating a restriction enzyme site.
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large number of cointegrates were obtained, as determined by PCR with primers
lacI up and lacA down (Table 1). The 42°C culture was then used to inoculate
LB containing KAN (12.5 g/ml) at 30°C, and log-phase growth was carried out
for 48 h at 30°C. Serial dilutions were then plated onto LB-KAN (S-Gal) plates
(Sigma-Aldrich, Dorset, United Kingdom) at 30°C. S-Gal plates allowed lac
mutant colonies to be easily identified. Colonies were then replica plated on
LB-KAN, LB-CAM, and LB plates at 30°C to determine if gene replacements
had been obtained. Colonies that appeared to have undergone allelic exchange
were analyzed by PCR with primer pairs lac mid 5-lac mid 3 and lacI up 5-lacA
down 3 and plated on MacConkey agar indicator plates (Oxoid, Basingstoke,
United Kingdom) to confirm their lactose fermentation status. Loss of the
original plasmids was confirmed by PCR with pIB307-specific primers. ZAP1
with the lac region deleted but containing the sac kan cassette was termed
ZAP1001, the ZAP41 strain with lac deleted was termed ZAP1041, and the
ZAP193 strain with lac deleted was termed ZAP1193 (Table 3).
Construction of plasmids to facilitate single-copy promoter fusions. To allow
the activities of different promoters to be compared on the chromosome, plas-
mids suitable for allelic exchange containing a promoterless lacZ gene were
constructed. Primers lacZ 5 and lacZ 3 (Table 1) were used to amplify the lacZ
gene from pDG005 (Table 2). These primers incorporate BamHI sites at their 5
ends and BglII sites at their 3 termini, allowing cloning into pAJR26. The
resultant plasmid (pAJR39) contains single BamHI and KpnI sites 5 of the lacZ
gene, allowing promoters of interest with their initial coding sequence to be
cloned in frame with the reporter gene. In addition, the promoterless lacZ gene
was cloned into the BamHI site of pACYC184 with the same primers for con-
struction of low-copy-number plasmid-based promoter fusions.
Creation of single-copy reporter strains in E. coli O157. The reporter plasmids
derived from pAJR39 and pAJR40 were used to create single-copy chromosomal
fusions in place of the sac-kan cassette of ZAP1193. Putative promoter regions
for sepL and espA were amplified for five EHEC strains with appropriate primers
(Table 1). The promoters were cloned into an allelic-exchange vector (pAJR39)
to create a series of plasmids containing promoter-lacZ fusions as detailed in
Table 2 (pAJR43 to -48 and pAJR55 to -60). Individual plasmids containing the
sepL::lacZ or espA::lacZ fusion from the different EHEC strains were then
exchanged into the chromosome of ZAP1193 in place of the sac-kan cassette. To
achieve this, the plasmids were electroporated into the target strain and trans-
formants were selected on LB-CAM plates at 30°C. Ten transformants were then
inoculated into LB-CAM broth at 42°C and subcultured four times over a 48-h
period. Serial dilutions of these cultures were plated on LB-CAM plates at 42°C,
and individual colonies were screened for primary integrates with appropriate
primer pairs. Primary integrates were then inoculated into LB at 30°C for 48 h of
logarithmic growth, and serial dilutions were plated onto LB-sucrose (6%, wt/vol;
no NaCl) agar (4). Individual colonies were replica plated on LB, LB-CAM, and
LB-KAN at 30°C to identify those that had undergone successful allelic ex-
change. Selected promoters were also cloned into the pACYC184-based lacZ
fusion vector (Table 2).
Measurement of -galactosidase activity. Assays for -galactosidase were
performed as described in reference 44, with the following modifications. One
hundred microliters of bacterial culture was removed and permeabilized by
addition of 900 l of Z buffer (44), 75 l of CHCl3, and 37 l of 0.1% SDS and
vortexing for 10 s. The assay tubes were then incubated at 25°C for 5 min before
addition of 200 l of o-nitrophenyl--D-galactopyranoside (ONPG; 4 mg ml1).
The reaction was stopped by addition of 500 ml of 1 M NaCO3 to the reaction
mixture. To remove cell debris, the tubes were centrifuged for 4 min (10,000 
g; Beckman). The resulting supernatant was removed, the absorbances at 420 and
TABLE 2. Plasmids used in the study
Plasmid(s) Description
pIB307 ........................pMAK705-based vector for allelic exchange;
temperature-sensitive replicon (4)
pDG005......................Low-copy-number vector containing MG1655 lacZYA
region
pDG028......................Low-copy-number vector containing sac-kan cassette (21)
pACYC184.................Low-copy-number cloning vector
pAJR26 ......................lacIA flanking regions from ZAP193 cloned into pIB307
pAJR27 ......................lacIA flanking regions from ZAP1 cloned into pIB307
pAJR33 ......................pAJR26 with sac-kan cassette from pDG28 cloned
between lacIA fragments
pAJR34 ......................pAJR27 with sac-kan cassette from pDG28 cloned
between lacIA fragments
pAJR39 ......................pAJR26 with promoterless lacZ gene cloned between
lacIA fragments
pAJR43 to 48 ............pAJR39 with sepL promoter region from described ZAP
strain cloned in frame of lacZ (pAJR43, ZAP1;
pAJR44, ZAP21; pAJR45, ZAP41; pAJR46, ZAP46;
pAJR47, ZAP58; pAJR48, ZAP193)
pAJR55 to 60 ............pAJR39 with espA promoter region from described ZAP
strain cloned in frame of lacZ (pAJR55, ZAP1;
pAJR56, ZAP21; pAJR57, ZAP41; pAJR58, ZAP46;
pAJR59, ZAP58; pAJR60, ZAP193)
peGFP ........................Clontech commercial vector
pAJR70 ......................pACYC184 cut with BamHI, gfp gene cloned BamHI/
BglII
pAJR71 ......................pAJR70 cut with BamHI/KpnI; LEE1 promoter cloned
in frame 5 to gfp
pAJR72 ......................pAJR70 cut with BamHI/KpnI; LEE2 promoter cloned
in frame 5 to gfp
pAJR73 ......................pAJR70 cut with BamHI/KpnI; LEE3 promoter cloned
in frame 5 to gfp
pAJR74 ......................pAJR70 cut with BamHI/KpnI; LEE4 promoter cloned
in frame 5 to gfp
pAJR100 ....................pACYC184 cut with BamHI; lacZ gene cloned BamHI/
Bgl/II
pAJR101 ....................pAJR100 cut with BamHI/KpnI; LEE1 promoter cloned
in frame 5 to lacZ
pAJR102 ....................pAJR100 cut with BamHI/KpnI; LEE2 promoter cloned
in frame 5 to lacZ
pAJR103 ....................pAJR100 cut with BamHI/KpnI; LEE3 promoter cloned
in frame 5 to lacZ
pJTPr-2.......................pCB267 with LEE4 (sepL) promoter cloned 5 to lacZ
TABLE 3. Strains used in the study
Strain Details Source, reference
ZAP1 O157:H7 Redhouse Dairy human-outbreak strain phage type 2 Our stocks, 51
ZAP21 Bovine diarrhea strain STEC 413/89-1 Our stocks, 13
ZAP41 O157:H7 bovine strain Our stocks, 40
ZAP46 O157:H7 bovine strain Our stocks, 40
ZAP58 O157:H7 human disease outbreak strain Our stocks, 40
ZAP193 NCTC 12900; O157 stx Nalr Our stocks
ZAP198 O157 stx Nalr Our stocks, 49
ZAP1001 ZAP1 sac-kan lacZY This study
ZAP1041 ZAP41 sac-kan lacZY This study
ZAP1193 ZAP193 sac-kan lacZY This study
ZAP1193–sep1–5 ZAP1193 with sepL promoter regions from ZAP strains cloned
in frame with lacZ and exchanged in place of the sac-kan
cassette (sep-1, ZAP1; sep-2, ZAP21; sep-3, ZAP41; sep-4,
ZAP46; sep-5, ZAP58)
This study
ZAP1193–espA1–6 ZAP1193 with espA promoter regions from ZAP strains
cloned in frame with lacZ and exchanged in place of the
sac-kan cassette (espA1, ZAP1; espA2, ZAP21; espA3,
ZAP41; espA4, ZAP46; espA5, ZAP58, espA6, ZAP193)
This study
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550 nm were determined, and Miller units were calculated as previously de-
scribed (43).
Northern analysis. Bacterial cultures (250 ml) were grown in MEM-HEPES to
an OD600 of 0.8. Total RNA was extracted with a Qiagen RNeasy midi-prep kit
or Ambion Totally RNA kits in accordance with the manufacturer’s instructions.
RNA was quantified both spectrophotometrically (Cecil CE2021; Aurius) and by
running 2-l aliquots of total extracted RNA on nondenaturing Tris-borate-
EDTA gels with denaturing buffer (New England Biolabs). Electrophoresis of
RNA on 1.0% (wt/vol) agarose formaldehyde–morpholinepropanesulfonic acid
gels was performed as previously described (52). After electrophoresis, the RNA
was blotted onto Hybond-N nylon membranes (Amersham-Pharmacia Biotech)
by downward transfer (9) and UV cross-linked. RNA dot blot assays were
performed by hybridization of a range of RNA concentrations (10 to 0.1 ng)
directly onto a Hybond-N nylon membrane and UV cross-linking. Prehybridiza-
tion and hybridization for all blots were performed at 42°C with Ultrahyb buffer
(Ambion Inc.). Samples were probed with single-stranded DNA probes specific
for either espA, sepL, espD, or escC (Table 1) or pgi (phosphoglucose isomerase)
as a control (Table 1). Probes were labeled with [32P]dCTP and Ready-To-Go
DNA labeling beads (Amersham-Pharmacia Biotech). The 32P signal was re-
corded on BioMax MR film (Kodak, Rochester, N.Y.) and also detected with a
PhosphorImager (Bio-Rad GS-525; Bio-Rad), which allowed further quantifica-
tion with Multi-analyst software (Bio-Rad).
RESULTS
Medium-dependent secretion of EspA and -D is associated
with LEE1-4 expression levels. It is known that MEM-HEPES
is permissive for type III secretion of EspA, -B, and -D by
EPEC and EHEC (12, 14, 32, 40). By contrast, no secretion of
Esps was detected when six different strains of EHEC O157
were cultured in M9 minimal medium (data not shown). The
basis for this was investigated with LEE1, LEE2, LEE3, and
LEE4 translational fusions to egfp (pAJR71–74; Table 2) trans-
formed into Shiga-like-toxin-negative strain E. coli O157:H7
NCTC 12900 (ZAP193, Table 3). Expression from these pro-
moters was measured in MEM-HEPES and M9 minimal me-
dium (Fig. 1). Expression from all four operons was increased
in MEM-HEPES and was associated with the formation of
EspA filaments (Fig. 2a to d) and secretion of EspD and EspA
(data not shown) in MEM but not in M9 minimal medium. For
example, LEE1 expression was approximately fourfold higher
in MEM-HEPES (28,500 U) than in M9 minimal medium
(7,500 U) at the same optical density (OD600  0.6). The
difference was more pronounced for LEE3 expression, which
was approximately 10-fold higher in MEM-HEPES (9,500 U)
than in M9 minimal medium (940 U) at the same optical
density (OD600  0.6).
EspA filaments are expressed by a subpopulation of bacte-
ria. Initial characterization of nine wild-type E. coli O157
strains cultured in MEM-HEPES revealed that EspA filaments
were detectable only on a proportion of the bacteria. The
proportion depended on the strain and exact culture condi-
tions (Fig. 2 and 3) but varied from 1 to 95%. In order to study
this variation, it was necessary to have a consistent EspA phe-
notype to start any analysis. This was achieved by culturing
strains overnight in M9 minimal medium, which resulted in
lower levels of LEE1-4 expression (Fig. 1b) and no detectable
EspA filamentation (Fig. 2a and b). Strains were then subcul-
tured (to an OD600 of 0.05) into MEM-HEPES, which induced
LEE1-4 operon expression (Fig. 1a) and stimulated EspA fil-
ament expression and protein secretion (Fig. 2c to f). As shown
in Fig. 2c to f for ZAP193, only a proportion of the bacterial
population expressed EspA filaments and this proportion in-
creased throughout the exponential phase of growth but then
dropped off rapidly as the bacteria entered stationary phase
(Fig. 3). This pattern was reproducible and observed with dif-
ferent strains. Western blot analysis confirmed that the poly-
clonal anti-EspA antibody recognizes a 25-kDa protein, the
expected size of EspA (Fig. 4a).
High and low levels of EspD secretion by wild-type E. coli
O157:H7 strains correlates with the proportion of bacteria
that express EspA filaments. Our previous work has shown
that E. coli O157:H7 strains isolated from both human disease
outbreaks and cattle show a marked heterogeneity in their
level of EspD secretion into MEM-HEPES (40). To test
whether this heterogeneity was linked to the proportion of the
population expressing EspA filaments, two high-secretion and
two low-secretion strains (ZAP1,-41, -46, and -58; Table 3)
were cultured overnight in M9 minimal medium and then
subcultured into MEM-HEPES as described before. The bac-
teria were then sampled at different points in the growth curve
and the proportion of bacteria expressing EspA filaments was
determined, as well as the level of EspA and -D in the super-
natants. High-secretion strains ZAP1 and ZAP58 had easily
detectable levels of EspA and EspD in their supernatants at an
FIG. 1. Expression of LEE1-4 operons in MEM-HEPES (a) and
M9 minimal medium (b). LEE1-4 promoter-egfp fusions were con-
structed as described in Materials and Methods and transformed into
ZAP193 (Table 3). Fluorescence was assayed throughout the growth
curve as described in Materials and Methods and expressed as relative
fluorescence units (Au). Symbols: , LEE1; F, LEE2; Œ, LEE3; ,
LEE4.
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FIG. 2. Micrographs showing EspA and LEE1-4 expression from E. coli O157:H7. Bacteria were visualized by phase-contrast microscopy (a,
c, e, g, i, and k). EspA filaments were visualized by indirect immunofluorescence (b, d, f, h, and j) as described in Materials and Methods. (a and
b) ZAP193 cultured in M9 minimal medium. (c and d) ZAP193 cultured overnight in M9 minimal medium and then subcultured into
MEM-HEPES to an OD600 of 0.4. (e and f) ZAP193 cultured overnight in M9 minimal medium and then subcultured into MEM-HEPES to an
OD600 of 0.8. (g and h) ZAP41 cultured overnight in M9 minimal medium and then subcultured into MEM-HEPES to an OD600 of 0.8. (i and j)
ZAP58 cultured overnight in M9 minimal medium and then subcultured into MEM-HEPES to an OD600 of 0.8. (k and l) ZAP193 cultured in
MEM-HEPES overnight. Images m to p are of enhanced GFP fluorescence captured by confocal microscopy as described in Materials and
Methods. All of the bacteria visualized were fluorescent; therefore, phase images are not shown. m, LEE1::egfp in ZAP193; n, LEE2::egfp in
ZAP193; o, LEE3::egfp in ZAP193; p, LEE4::egfp in ZAP193.
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OD600 of 0.8, whereas the low-secretion strains had barely
detectable levels by comparison (Fig. 4a and b). Increased
exposure of the blots did permit detection of EspA and -D
from strains ZAP41 and -46 (data not shown). The high-secre-
tion strains had a higher proportion of bacteria producing
EspA filaments at the three optical densities examined (Fig.
4c). When strains were cultured overnight in MEM-HEPES
(rather than M9 minimal medium) and subcultured into
MEM-HEPES, the proportion of EspA bacteria increased,
with high-secretion strains giving populations containing 70 to
95% EspA bacteria, whereas low secretors remained under
30% (Fig. 2k and l, Fig. 4c and data not shown). These growth
conditions produced the largest disparity in EspA filamenta-
tion between high- and low-secretor strains and were used to
analyze differences in mRNA transcript levels (shown later in
this report).
Production of EspA filaments by individual bacteria does
not correlate with LEE1-4 expression. The LEE1, -2, -3, and
-4::egfp fusions on pACYC184 in E. coli O157:H7 (ZAP193)
were used to determine if the variable expression of EspA
filaments resulted from differences in expression from the
LEE1-4 promoters in individual cells. Bacteria were again cul-
tured overnight in M9 minimal medium and then subcultured
into MEM-HEPES. While the proportion of bacteria express-
ing EspA filaments was again variable, GFP levels in each cell
were very similar, as shown by fluorescence and confocal mi-
croscopy at all of the optical densities examined (Fig. 2m to p).
In addition, the LEE1-4 promoters from E. coli O157:H7
(ZAP1) were cloned in front of lacZ and transformed into
ZAP1 and ZAP41 derivatives with the lacZY region deleted
(Table 3). The levels of -galactosidase from each promoter
fusion were equivalent in the two strain backgrounds when the
bacteria were cultured in MEM-HEPES (Table 4). Previous
work with primer extension has revealed at least two putative
promoters for espADB (LEE4) (2, 43), so single-copy, chromo-
somally integrated lacZ constructs to both regions were made
in ZAP1193 (lac, Materials and Methods). This allowed pu-
tative promoters from different strains to be analyzed in an E.
coli O157:H7 (lac) high-secretor background. No activity
FIG. 3. EspA filament expression during the growth of E. coli
O157:H7. ZAP193 was cultured overnight in M9 minimal medium and
subcultured into MEM-HEPES to an OD600 of 0.05. Bacteria were
labeled to detect EspA filaments as described in Materials and Meth-
ods. The results of a typical experiment are shown. Experiments were
repeated three times for both ZAP193 and ZAP198, and both strains
gave the same pattern of expression.
FIG. 4. Analysis of EspA and EspD expression by E. coli O157
strains. Western blot analysis of EspA (A) and EspD (B) in bacterial
supernatants from four wild-type E. coli O157 strains: ZAP1, ZAP58
(both high secretors), ZAP41, and ZAP46 (both low secretors). Bac-
teria were cultured overnight in M9 minimal medium and subcultured
into MEM-HEPES. The supernatants were obtained at an OD600 of
0.8, and proteins were separated and detected as described in Mate-
rials and Methods. (C) Proportions of bacteria expressing EspA fila-
ments were determined by immunofluorescence microscopy as de-
scribed in Materials and Methods. Samples were prepared at OD600s
of 0.4 (u); 0.8 (); and 1.2 ().
TABLE 4. Miller assay results for plasmid-based LEE1–4 promoter
fusions to -galactosidase in high- and low-secretor E. coli O157
EspD backgrounds
Plasmid
Avg no. of Miller units 	 SD (n  3)
ZAP1001a
(high secretor)
ZAP1041a
(low secretor)
pAJR101 (LEE1::lacZ) 7,429 	 122 7,659 	 187
pAJR102 (LEE2::lacZ) 2,364 	 79 1,984 	 97
pAJR103 (LEE3::lacZ) 113 	 11 144 	 45
pJTPr-2 (LEE4::lacZ) 353 	 57 351 	 42
a Strains were grown in MEM-HEPES to an OD600 of 0.6, and Miller assays
were carried out as described in Materials and Methods.
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from espA promoters was detected under permissive secretion
conditions, in contrast to the sepL promoter regions, which
gave measurable and equivalent activity for the regions cloned
from five E. coli EHEC strains (Table 5). Sequence analysis
demonstrated that all five regions were identical over a 220-bp
region proximal to the sepL AUG start codon (data not
shown).
Translocon protein secretion is inversely related to levels of
the espADB mRNA transcript. The levels of LEE4 mRNA in
two high-secretor and two low-secretor strains were investi-
gated. In order to maximize the secretion differences between
the strains, overnight MEM-HEPES cultures were used to
inoculate MEM-HEPES for exponential growth and samples
were taken at an OD600 of 0.8. For the high-secretion strains,
this produced populations that had more than 80% of the
bacteria expressing EspA filaments, compared to less than
30% for the low-secretor strains. Northern analysis was carried
out with probes to sepL, espA, and espD mRNAs. As shown in
Fig. 5a, all of the strains produced equivalent levels of a 1- to
1.5-kb transcript when a sepL probe was used. In addition, a
faint band of approximately 5 kb was detected. This concurs
with previous work suggesting that initially a 5.6-kb transcript
is produced from the sepL promoter, which is then processed
to give separate species, including the 2.8-kb espADB and
1.5-kb sepL mRNAs (22, 43). Both low-secretion strains
(ZAP41 and ZAP46) were found to contain an mRNA tran-
script of approximately 3 kb (Fig. 5b and c) when either an
espA or an espD probe was used. In contrast, the same tran-
script was less abundant in high-secretion strains (Fig. 5b and
c). As controls, the RNA extracts were probed for LEE2 (escC)
and phosphoglucose isomerase (pgi) transcripts. The strains
were found to contain very similar levels of both of these
transcripts (Fig. 5d and data not shown).
The abundance of the espADB mRNA in the two low-secre-
tor strains prompted the question of whether this mRNA is
translated and the protein is maintained in the cell as a pool
rather than being secreted. Western blots were carried out on
the high- and low-secretor strains for EspD present in whole
cells, membranes, and supernatants (Fig. 6). There were equiv-
alent and relatively low levels of EspD detectable in whole cells
of both phenotypes, and most of this protein was membrane
associated.
DISCUSSION
The aim of this study was to investigate the molecular basis
of the variation in secreted EspD levels demonstrated by wild-
type E. coli O157:H7 strains (40). Previous work had shown
FIG. 5. Northern analyses of LEE operon expression. Detection of
transcript mRNA with an sepL probe (a) in high- and low-secretor strains:
ZAP1 and -58 (high secretors, Table 3) and ZAP41 and -46 (low secre-
tors, Table 3). The top arrow indicates a transcript of approximately 5 kb,
and the lower arrow indicates a transcript of approximately 1.2 kb. De-
tection of transcript mRNA with an espA probe (b) and an espD probe (c).
The arrow indicates a transcript of approximately 3 kb. Detection of
transcript mRNA with a LEE2 (escC) probe (d) in high- and low-secretor
strains. The arrow indicates a transcript of approximately 3 kb. All strains
(Table 3) were grown in MEM-HEPES to an OD600 of 0.6, and the total
RNA was extracted as described in Materials and Methods. The probes
used are defined in Table 2.
TABLE 5. Miller assay results obtained with chromosomal sepL
and espA translational fusions to lacZ in EHEC O157 ZAP1193
Promoter source
Avg no. of Miller units (	 SD, n  3)
for indicated chromosomally integrated
translational -galactosidase fusions in
ZAP1193a
sepL::lacZ espA::lacZ
ZAP1 50 	 2 3 	 2
ZAP21 50 	 3 4 	 2
ZAP41 49 	 1 2 	 1
ZAP46 49 	 2 2 	 1
ZAP58 47 	 2 4 	 1
ZAP193 NDb 2 	 1
No promoter 2 	 1 2 	 1
a Strains were grown in MEM-HEPES to an OD600 of 0.6, and Miller assays
were carried out as described in Materials and Methods.
b ND, not determined for this construct.
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that the majority of cattle isolates secrete significantly lower
levels of EspD than do many human outbreak strains. This
research therefore focused on the expression of the LEE4
translocon proteins, EspA and EspD, in both high- and low-
secretion strains.
EspA filaments were visualized on the surface of the bacte-
ria by indirect immunofluorescence assay with an anti-EspA
polyclonal antibody. Initial experiments examined a number of
wild-type strains and demonstrated that only a proportion of
the bacteria expressed EspA filaments and that strains origi-
nally characterized as high secretors had the populations with
the highest proportions of EspA-positive bacteria. Such inher-
ent heterogeneity makes it difficult to compare expression lev-
els between strains. In this case, it was decided to start strains
from an equal point, overnight growth in M9 minimal medium,
which fails to induce secretion of the translocon proteins (Fig.
2), and study the transition to their expression in MEM-
HEPES. Growth in MEM-HEPES increases LEE1-4 expres-
sion, resulting in secretion of EspA and -D (Fig. 1a). With this
comparison, high secretors expressed filaments on a higher
proportion of the population than did low-secretor strains (Fig.
2). These differences were supported by Western blot analysis
of EspD and EspA levels in the bacterial supernatants (Fig. 4a
and b). Attempts were made to quantitate the levels of fila-
ment-positive and -negative bacteria by flow cytometry, but the
preparation steps resulted in the loss of EspA filaments, which
appear extremely fragile in comparison to other surface ap-
pendages, such as fimbriae and flagella. The pattern of EspA
expression was analyzed in more detail with two high-secretor
Shiga-like toxin-negative E. coli O157 strains (ZAP193 and
-198, Table 3). The highest proportions of EspA bacteria
were shown to be present in late exponential phase, with fila-
ments lost rapidly from these positive cells once the cultures
entered stationary phase. Growth phase-dependent expression
of translocon proteins has been observed for E. coli O157:H7,
linked to quorum sensing (29, 56).
The molecular basis of this heterogeneity was then investi-
gated. As with many phase-variable systems, we attempted to
demonstrate variation at the transcriptional level with GFP
and lacZ fusions to LEE4 both on low-copy-number vectors
and by single-copy fusions exchanged into the chromosome.
Previous reports have demonstrated that a promoter in front of
sepL drives expression of LEE4 and espADB in EPEC but that
a promoter in front of espA drives LEE4 expression in EHEC
O157 (2, 22, 43). Our data reported here (and unpublished),
which were obtained with promoter regions amplified from five
E. coli O157 strains, show no evidence of any expression from
a promoter in front of espA, with expression only detectable
from sepL. None of these constructs displayed any phase-vari-
able expression, either at the single-cell level (GFP fusions) or
at the colony level (lacZ fusions). In addition to LEE4, analysis
of LEE1-3 GFP fusions in ZAP193 also demonstrated consis-
tent expression at the single-cell level under conditions that
produce heterogeneous expression of EspA filaments (Fig. 2i
to k). Taken together, the data indicate that the heterogeneity
in EspA filament production, and therefore high- and low-level
secretion, is controlled posttranscriptionally.
LEE4 mRNA levels were analyzed by Northern blotting with
probes for sepL, espA, and espD. Expression from a promoter
in front of sepL would produce an initial transcript length of
approximately 5.6 kb (if expression occurs to the end of espF),
as shown in two previous studies with EPEC (22, 43). Equiv-
alent levels of sepL-containing transcripts were detected in
both high- and low-secretor strains, confirming the fusion data
that indicated no variation in expression from this promoter
between the strains. The detection of two sepL transcripts
indicates some processing of the initial 5.6-kb message. This
processing of the transcript may explain the 1 transcriptional
start site mapped for espA by Beltrametti et al. (2), as this
could instead be an mRNA cleavage site. Probes directed
against espA and espD both revealed a transcript of approxi-
mately 3 kb which will be the mRNA transcript for espA, espD,
and espB. The intriguing result, obtained with both probes, was
that this transcript was more abundant in the low-secretor
strains than in the high-secretor strains; i.e., there is an inverse
relationship between secreted protein (EspA and EspD) levels
and detection of the associated espADB mRNA transcript.
Control probes for LEE2 and phosphoglucose isomerase tran-
scripts displayed little variation between the high- and low-
secretor strains. Taken together with the fusion data, the data
show that LEE4 is transcribed at the same level in both high-
and low-secretor strains but translation and secretion of Esps is
then restricted in the majority of bacteria in a low-secretor
population. This was confirmed by an analysis of EspD levels in
whole cells that showed that the abundant transcript was not
being translated to give an intracellular pool of Esps in low-
secretor strains and any EspD appeared to be associated with
the cell membrane (Fig. 6c). The checkpoint in secretion there-
fore appears to lie in translation of the transcript. The reason
for the much lower detectable levels of LEE4 and espADB
mRNAs in the high-secretor strains is unknown, but this was
repeatedly demonstrated with both espA and espD probes. One
possibility is that secretion and translation are coupled at the
type III secretion system, as suggested for the related Salmo-
nella enterica serovar Typhimurium flagellar export system
(30). If the mRNA is engaged within a type III secretion
complex during secretion of EspADB, it may be more difficult
to extract. Differences in the half-lives of the transcripts may
also explain the findings and are being investigated. The con-
cept of a checkpoint in Yop secretion at the posttranscriptional
level has been discussed by Anderson and Schneewind for
Yersinia sp. (1).
One conclusion from the data presented is that EspA secre-
FIG. 6. EspD localization in E. coli O157:H7. ZAP1, -41, -193, and
-58 were cultured overnight in MEM-HEPES, subcultured into MEM-
HEPES, and grown to an OD600 of 0.8. Supernatant (SN), whole-cell
(WC), and membrane (M) proteins were prepared as described in
Materials and Methods. Western blotting for EspD was carried out as
described in Materials and Methods.
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tion is phase variable in E. coli O157 and controlled at the
posttranscriptional level, although the mechanism responsible
for this variation remains to be demonstrated. The extent of
this variation differs between strains and accounts for the ob-
served differences in protein secretion levels (40). The popu-
lation can be divided into bacteria that have EspA filaments
and are actively secreting proteins and those that have no
filaments and presumably are not secreting. Expression levels
of the LEE1-4 operons are equivalent in both populations; the
difference between them is that in the secreting subpopulation,
the espADB transcript is being translated, leading to translocon
production, whereas in the other subpopulation, translation is
checked. High-secretor strains contain a higher proportion of
cells that are actively producing the translocon proteins,
whereas in the low-secretor strains, this proportion of cells is
much lower. Phase variation of the TTSS translocon may keep
expression limited in vivo, reducing the likelihood of an im-
mune response to these antigens. In addition, the variation
may allow other adhesins to function on the bacterial cell
surface without interference from EspA filaments. Such ad-
hesins may drive initial binding of EHEC O157, which could
then lead to production of the translocon apparatus. A post-
transcriptional checkpoint would have the translocon appara-
tus primed for immediate expression in response to a suitable
stimulus. Recent work suggests that flagellar phase variation in
S. enterica is controlled by a posttranscriptional mechanism in
which a control protein is proposed to bind to the 5 untrans-
lated region of the flagellar transcript, inhibiting ribosome
binding and translation (5). For E. coli O157:H7, current work
is attempting to identify factors that interact with the LEE4
mRNA transcript, including both proteins and small RNAs.
The production of EspA filaments therefore requires the
right environmental conditions to lead to expression of
LEE1-4, but then a further restriction is placed on whether of
not the LEE4 espADB mRNA transcript is translated. To date,
we have no evidence that this heterogeneous expression occurs
in EPEC O127 strain E2348/69, suggesting that it may not be
subject to the same posttranscriptional restriction. This differ-
ence could account for the finding that the cloned EPEC LEE
in E. coli K-12 does lead to Esp secretion and attaching-and-
effacing lesion formation, whereas the cloned EHEC O157
LEE does not (16, 39). We therefore speculate that a phase-
variable factor, possibly not encoded on the LEE, enables
translation of the espABD message in E. coli O157:H7. This
further control of Esp production may be important for the
success of the bacterium in ruminants, especially cattle. EPEC
in humans and animals causes an acute and generalized infec-
tion of the gastrointestinal tract to which there is a strong
adaptive immune response. This may, in part, result from less
restricted Esp expression. By contrast, E. coli O157:H7 colo-
nizes the terminal rectum in cattle (45), with no apparent
immune response (our unpublished data), and can persist at
this site for many weeks. The low-secretion phenotype dis-
played by the majority of bovine E. coli O157:H7 strains may
be necessary to keep the expression of the type III secreted
factors restricted until required at the specific colonization site.
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